{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:25:19Z","timestamp":1777937119535,"version":"3.51.4"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Medicine Open"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ajmo.2025.100117","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T04:17:50Z","timestamp":1757650670000},"page":"100117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hospital Care for Pregnant Persons With OUD Review"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2203-5687","authenticated-orcid":false,"given":"Joan","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mishka","family":"Terplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajmo.2025.100117_bib0001","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017 [published correction appears in JAMA. 2021 Jun 8;325(22):2316. 10.1001\/jama.2021.8098]","volume":"325","author":"Hirai","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajmo.2025.100117_bib0002","series-title":"Pregnancy-Related Deaths: Data from Maternal Mortality Review Committees in 36 US States, 2017\u20132019","author":"Trost","year":"2022"},{"issue":"6","key":"10.1016\/j.ajmo.2025.100117_bib0003","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013-2019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.ajmo.2025.100117_bib0004","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/AOG.0000000000003907","article-title":"Polysubstance use among pregnant women with opioid use disorder in the United States, 2007-2016","volume":"136","author":"Jarlenski","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ajmo.2025.100117_bib0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.whi.2023.06.002","article-title":"Risk of severe maternal morbidity in birthing people with opioid use disorder","volume":"33","author":"Osei-Poku","year":"2023","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.ajmo.2025.100117_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107679","article-title":"Unmet substance use disorder treatment need among reproductive age women","volume":"206","author":"Martin","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ajmo.2025.100117_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107652","article-title":"Treatment for substance use disorders in pregnant women: motivators and barriers","volume":"205","author":"Frazer","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.ajmo.2025.100117_bib0008","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11606-016-3919-4","article-title":"It\u2019s been an experience, a life learning experience\u201d: a qualitative study of hospitalized patients with substance use disorders","volume":"32","author":"Velez","year":"2017","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ajmo.2025.100117_bib0009","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s11606-017-4077-z","article-title":"Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity","volume":"32","author":"Wakeman","year":"2017","journal-title":"J GEN INTERN MED"},{"key":"10.1016\/j.ajmo.2025.100117_bib0010","doi-asserted-by":"crossref","first-page":"899","DOI":"10.7326\/M20-5475","article-title":"Preventing hospital readmission for patients with comorbid substance use disorder: a randomized trial","volume":"174","author":"Gryczynski","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajmo.2025.100117_sbref0011","series-title":"Academy of Perinatal Harm Reduction","year":"2024"},{"key":"10.1016\/j.ajmo.2025.100117_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111324","article-title":"Patient navigation for perinatal substance use disorder treatment: a systematic review","volume":"260","author":"Wouk","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ajmo.2025.100117_bib0013","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711. American College of Obstetricians and Gynecologists","volume":"130","author":"Mascola","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajmo.2025.100117_bib0014","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s10995-021-03258-5","article-title":"Racial and ethnic differences in urine drug screening on labor and delivery","volume":"26","author":"Winchester","year":"2022","journal-title":"Matern Child Health J"},{"issue":"5","key":"10.1016\/j.ajmo.2025.100117_bib0015","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/AOG.0000000000005385","article-title":"Racial inequities in drug tests ordered by clinicians for pregnant people who disclose prenatal substance use","volume":"142","author":"Olaniyan","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ajmo.2025.100117_bib0016","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/AOG.0000000000004657","article-title":"What obstetrician\u2013Gynecologists should know about substance use disorders in the perinatal period","volume":"139","author":"Smid","year":"2022","journal-title":"Obstetrics & Gynecology"},{"key":"10.1016\/j.ajmo.2025.100117_bib0017","unstructured":"Prenatal drug exposure: CAPTA reporting requirements ... If\/When\/How 2024 https:\/\/ifwhenhow.org\/wp-content\/uploads\/2024\/02\/2024-Prenatal-Drug-Exposure-CAPTA-Reporting-Requirements-for-Medical-Professionals.pdf."},{"issue":"2","key":"10.1016\/j.ajmo.2025.100117_bib0018","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jat\/bkv133","article-title":"A retrospective analysis of urine drugs of abuse immunoassay true positive rates at a national reference laboratory","volume":"40","author":"Johnson-Davis","year":"2016","journal-title":"J Anal Toxicol"},{"issue":"2","key":"10.1016\/j.ajmo.2025.100117_bib0019","doi-asserted-by":"crossref","first-page":"175","DOI":"10.36076\/ppj.2011\/14\/175","article-title":"Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC\/MS\/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients","volume":"14","author":"Manchikanti","year":"2011","journal-title":"Pain Physician"},{"issue":"1","key":"10.1016\/j.ajmo.2025.100117_bib0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/0897190010380463","article-title":"Interferences with urine drug screens","volume":"24","author":"Herring","year":"2011","journal-title":"J Pharm Pract"},{"issue":"6","key":"10.1016\/j.ajmo.2025.100117_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2022.11.1293","article-title":"Fentanyl in the labor epidural impacts the results of intrapartum and postpartum maternal and neonatal toxicology tests","volume":"228","author":"Siegel","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ajmo.2025.100117_bib0022","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/WNF.0b013e318261e193","article-title":"Co-occurring psychotic and addictive disorders: neurobiology and diagnosis","volume":"35","author":"Ross","year":"2012","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.ajmo.2025.100117_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2021.107214","article-title":"Intimate partner violence as a predictor of substance use outcomes among women: a systematic review","volume":"127","author":"Ogden","year":"2022","journal-title":"Addict Behav"},{"issue":"12","key":"10.1016\/j.ajmo.2025.100117_bib0024","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1111\/add.15582","article-title":"Outcomes associated with the use of medications for opioid use disorder during pregnancy","volume":"116","author":"Krans","year":"2021","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.ajmo.2025.100117_bib0025","article-title":"Maintenance agonist treatments for opiate-dependent pregnant women","volume":"11","author":"Minozzi","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ajmo.2025.100117_bib0026","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/AOG.0000000000002562","article-title":"Opioid detoxification during pregnancy: a systematic review","volume":"131","author":"Terplan","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"22","key":"10.1016\/j.ajmo.2025.100117_bib0027","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa2203318","article-title":"Buprenorphine versus methadone for opioid use disorder in pregnancy","volume":"387","author":"Suarez","year":"2022","journal-title":"N Engl J Med"},{"issue":"1\u20133","key":"10.1016\/j.ajmo.2025.100117_bib0028","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2012.07.001","article-title":"Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of pregnant Women in Norway from 1996 to 2009","volume":"127","author":"Welle-Strand","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.ajmo.2025.100117_bib0029","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/jamainternmed.2023.6986","article-title":"First trimester use of buprenorphine or methadone and the risk of congenital malformations [published correction appears in JAMA Intern Med. 2024 Aug 1;184(8):993. 10.1001\/jamainternmed.2024.3261.]","volume":"184","author":"Suarez","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.ajmo.2025.100117_bib0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/pathophysiology30010004","article-title":"Safety and efficacy of buprenorphine-naloxone in pregnancy: a systematic review of the literature","volume":"30","author":"Ordean","year":"2023","journal-title":"Pathophysiology"},{"issue":"12","key":"10.1016\/j.ajmo.2025.100117_bib0031","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/j.1360-0443.2010.03120.x","article-title":"Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis","volume":"105","author":"Cleary","year":"2010","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.ajmo.2025.100117_bib0032","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1542\/peds.2014-3299","article-title":"Prescription opioid epidemic and infant outcomes","volume":"135","author":"Patrick","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajmo.2025.100117_bib0033","doi-asserted-by":"crossref","first-page":"j3326","DOI":"10.1136\/bmj.j3326","article-title":"Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study","volume":"358","author":"Huybrechts","year":"2017","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.ajmo.2025.100117_bib0034","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1542\/hpeds.2018-0227","article-title":"Increased severity of neonatal abstinence syndrome associated with concomitant antenatal opioid and benzodiazepine exposure","volume":"9","author":"Sanlorenzo","year":"2019","journal-title":"Hosp Pediatr"},{"issue":"4","key":"10.1016\/j.ajmo.2025.100117_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.06.029","article-title":"An evidence-based recommendation to increase the dosing frequency of buprenorphine during pregnancy","volume":"217","author":"Caritis","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajmo.2025.100117_bib0036","article-title":"Association between buprenorphine dose and outcomes among pregnant persons with opioid use disorder","author":"Jarlenski","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ajmo.2025.100117_bib0037","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.34540","article-title":"Buprenorphine dose and time to discontinuation among patients with opioid use disorder in the era of fentanyl","volume":"6","author":"Chambers","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.ajmo.2025.100117_bib0038","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/add.70002","article-title":"The association between buprenorphine doses above 16 milligrams and treatment retention in a multi-payer national sample in the United States, 2014 to 2021","volume":"120","author":"Stringfellow","year":"2025","journal-title":"Addiction"},{"key":"10.1016\/j.ajmo.2025.100117_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109398","article-title":"Trends in seizures of powders and pills containing illicit fentanyl in the United States, 2018 through 2021","volume":"234","author":"Palamar","year":"2022","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.ajmo.2025.100117_bib0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/11531740-000000000-00000","article-title":"Formulations of fentanyl for the management of pain","volume":"70","author":"Grape","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.ajmo.2025.100117_bib0041","unstructured":"National practice guideline for the use of medications in the treatment of addiction involving opioid use. Available at: http:\/\/www.asam.org\/docs\/default-source\/practicesupport\/guidelines-and-consensus-docs\/national-practice-guideline.pdf. Accessed: June 4, 2015."},{"issue":"4","key":"10.1016\/j.ajmo.2025.100117_bib0042","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/ADM.0000000000000945","article-title":"Low dose initiation of buprenorphine: a narrative review and practical approach","volume":"16","author":"Cohen","year":"2022","journal-title":"J Addict Med"},{"issue":"6","key":"10.1016\/j.ajmo.2025.100117_bib0043","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/ADM.0000000000001202","article-title":"ASAM clinical considerations: buprenorphine treatment of opioid use disorder for individuals using high-potency synthetic opioids","volume":"17","author":"Weimer","year":"2023","journal-title":"J Addict Med"},{"issue":"4","key":"10.1016\/j.ajmo.2025.100117_bib0044","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/ADM.0000000000001324","article-title":"Piloting a hospital-based rapid methadone initiation protocol for fentanyl","volume":"18","author":"Liu","year":"2024","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.ajmo.2025.100117_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)21130-2","article-title":"Altered methadone pharmacokinetics in methadone-maintained pregnant women","volume":"233","author":"Pond","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.ajmo.2025.100117_bib0046","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ajog.2013.10.010","article-title":"Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers","volume":"210","author":"Jones","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajmo.2025.100117_bib0047","series-title":"Treatment Improvement Protocol (TIP) Series 63 Publication No. PEP21-02-01-002","article-title":"Medications for opioid use disorder","year":"2021"},{"issue":"2","key":"10.1016\/j.ajmo.2025.100117_bib0048","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajmo.2025.100117_bib0049","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s40265-017-0762-9","article-title":"A retrospective cohort study of obstetric outcomes in opioid-dependent women treated with implant naltrexone, oral methadone or sublingual buprenorphine, and non-dependent controls","author":"Kelty","year":"2017","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.ajmo.2025.100117_bib0050","article-title":"Neurobehavioral outcomes of infants exposed to buprenorphine-naloxone compared with naltrexone during pregnancy","volume":"230","author":"Hulse","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajmo.2025.100117_bib0051","doi-asserted-by":"crossref","unstructured":"Lim, G., Carvalho, B., George, R., et al. (9900). Consensus Statement on Pain management for pregnant patients with opioid-use Disorder from the Society for Obstetric Anesthesia and Perinatology, Society for Maternal-Fetal Medicine, and American Society of Regional Anesthesia and Pain Medicine. Anesth Analg, Publish Ahead of Print, doi: 10.1213\/ANE.0000000000007237.","DOI":"10.1213\/ANE.0000000000007237"},{"issue":"3","key":"10.1016\/j.ajmo.2025.100117_bib0052","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/AOG.0000000000005510","article-title":"Naltrexone compared with buprenorphine or methadone in pregnancy: a systematic review","volume":"143","author":"Atluru","year":"2024","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ajmo.2025.100117_bib0053","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ajog.2016.10.003","article-title":"Opioid dependence and pregnancy: minimizing stress on the fetal brain","volume":"216","author":"McCarthy","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ajmo.2025.100117_bib0054","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/08897077.2019.1671942","article-title":"Understanding why patients with substance use disorders leave the hospital against medical advice: a qualitative study","volume":"41","author":"Simon","year":"2020","journal-title":"Subst Abus"},{"issue":"2S Suppl 1","key":"10.1016\/j.ajmo.2025.100117_bib0055","first-page":"1","article-title":"The ASAM National Practice Guideline for the treatment of Opioid use disorder: 2020 focused update [published correction appears in J Addict Med. 2020 May\/Jun;14(3):267. 10.1097\/ADM.0000000000000683.]","volume":"14","author":"Cunningham","year":"2020","journal-title":"J Addict Med"},{"issue":"9","key":"10.1016\/j.ajmo.2025.100117_bib0056","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"CIHR Canadian Research Initiative in Substance Misuse. Management of opioid use disorders: a national clinical practice guideline","volume":"190","author":"Bruneau","year":"2018","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.ajmo.2025.100117_bib0057","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamainternmed.2023.7282","article-title":"Caring for hospitalized adults with opioid use disorder in the era of Fentanyl: a review","volume":"184","author":"Englander","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.ajmo.2025.100117_bib0058","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13722-023-00368-z","article-title":"Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder","volume":"18","author":"Thakrar","year":"2023","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.ajmo.2025.100117_bib0059","unstructured":"Texas Tech University Health Sciences Center. (n.d.). Infantrisk Center. InfantRisk Center. https:\/\/infantrisk.com\/"},{"key":"10.1016\/j.ajmo.2025.100117_bib0060","unstructured":"Welcome to Reprotox. Reprotox. (n.d.). https:\/\/reprotox.org\/"},{"key":"10.1016\/j.ajmo.2025.100117_bib0061","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cpt196783415","article-title":"A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly and of orally and parenterally administered methadone","volume":"8","author":"Beaver","year":"1967","journal-title":"Clin Phar-Macol Ther"},{"issue":"12","key":"10.1016\/j.ajmo.2025.100117_bib0062","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1007\/s11606-020-06115-3","article-title":"Treating perioperative and acute pain in patients on Buprenorphine: narrative literature review and practice recommendations","author":"Buresh","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1016\/j.ajmo.2025.100117_bib0063","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-144-2-200601170-00010","article-title":"Acute pain management for patients receiving maintenance methadone or buprenorphine therapy","volume":"144","author":"Alford","year":"2006","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ajmo.2025.100117_bib0064","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/AOG.0000000000004357","article-title":"Association of patient sex and pregnancy status with naloxone administration during emergency department visits","volume":"137","author":"Forbes","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajmo.2025.100117_bib0065","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/978-0-387-73693-8_85","article-title":"Naloxone reversal of opioid-induced respiratory depression with special emphasis on the partial agonist\/antagonist buprenorphine","volume":"605","author":"Sarton","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.ajmo.2025.100117_bib0066","doi-asserted-by":"crossref","first-page":"S386","DOI":"10.1016\/j.ajog.2021.11.646","article-title":"Maternal mortality among persons with illicit substance use","volume":"226","author":"Nidey","year":"2022","journal-title":"Am J Obstetr Gynecol"},{"issue":"2","key":"10.1016\/j.ajmo.2025.100117_bib0067","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/add.14825","article-title":"Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery","volume":"115","author":"Schiff","year":"2020","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.ajmo.2025.100117_bib0068","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/AOG.0000000000005115","article-title":"Postpartum opioid-related mortality in patients with public insurance","volume":"141","author":"Suarez","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ajmo.2025.100117_bib0069","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/0890334407300336","article-title":"Concentrations of methadone in breast milk and plasma in the immediate perinatal period","author":"Jansson","year":"2007","journal-title":"J Hum Lact"},{"issue":"1","key":"10.1016\/j.ajmo.2025.100117_bib0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1940-0640-9-19","article-title":"Review of the assessment and management of neonatal abstinence syndrome","volume":"9","author":"Bagley","year":"2014","journal-title":"Addict Sci Clin Pract"},{"issue":"10","key":"10.1016\/j.ajmo.2025.100117_bib0071","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/bfm.2023.29256.abm","article-title":"Academy of Breastfeeding Medicine Clinical protocol #21: breastfeeding in the setting of substance use and substance use disorder (Revised 2023)","volume":"18","author":"Harris","year":"2023","journal-title":"Breastfeed Med"},{"issue":"6","key":"10.1016\/j.ajmo.2025.100117_bib0072","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.whi.2016.09.002","article-title":"A moral or medical problem: the relationship between legal penalties and treatment practices for opioid use disorders in pregnant women","volume":"26","author":"Angelotta","year":"2016","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.ajmo.2025.100117_bib0073","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.ajmo.2025.100117_bib0074","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajmo.2025.100117_bib0075","unstructured":"Waiver elimination (mat act). SAMHSA. (n.d.). https:\/\/www.samhsa.gov\/substance-use\/treatment\/statutes-regulations-guidelines\/mat-act\/."},{"issue":"1","key":"10.1016\/j.ajmo.2025.100117_bib0076","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/ADM.0000000000001246","article-title":"Dispensing methadone at hospital discharge: one hospital's approach to implementing the ``72-hour rule'' change","volume":"18","author":"Skogrand","year":"2024","journal-title":"J Addict Med"},{"issue":"9","key":"10.1016\/j.ajmo.2025.100117_bib0077","article-title":"Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification","author":"Amato","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ajmo.2025.100117_bib0078","first-page":"976","article-title":"Psychosocial correlates of drug and heavy alcohol use among pregnant women at risk for drug use","volume":"80","author":"Bresnahan","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajmo.2025.100117_bib0079","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.2105\/AJPH.2015.302821","article-title":"Women-centered drug treatment services and need in the United States, 2002\u20132009","volume":"105","author":"Terplan","year":"2015","journal-title":"Am J Public Health"}],"container-title":["American Journal of Medicine Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667036425000317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667036425000317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T04:19:10Z","timestamp":1765253950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667036425000317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":79,"alternative-id":["S2667036425000317"],"URL":"https:\/\/doi.org\/10.1016\/j.ajmo.2025.100117","relation":{},"ISSN":["2667-0364"],"issn-type":[{"value":"2667-0364","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hospital Care for Pregnant Persons With OUD Review","name":"articletitle","label":"Article Title"},{"value":"American Journal of Medicine Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajmo.2025.100117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100117"}}